Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Income Statement [Abstract]
REVENUES	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
Research and development expenses	1,094,000	969,000	2,091,000	1,404,000
General and administrative expenses	943,000	455,000	2,070,000	977,000
Depreciation and amortization	116,000	62,000	227,000	75,000
TOTAL OPERATING EXPENSES	2,153,000	1,486,000	4,388,000	2,456,000
OPERATING LOSS	(2,153,000)	(1,486,000)	(4,388,000)	(2,456,000)
OTHER INCOME (EXPENSE)
Interest and investment income	8,000	2,000	16,000	2,000
Interest expense	0	(2,099,000)	0	(2,808,000)
Fair value adjustments to warrant and derivative liabilities	0	252,000	0	(2,015,000)
Other income	0	1,164,000		1,164,000
TOTAL OTHER INCOME (EXPENSE)	8,000	(681,000)	16,000	(3,657,000)
LOSS BEFORE INCOME TAXES	(2,145,000)	(2,167,000)	(4,372,000)	(6,113,000)
Provision for income taxes	0	0	(1,000)	(1,000)
NET LOSS	$ (2,145,000)	$ (2,167,000)	$ (4,373,000)	$ (6,114,000)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share)	$ (0.31)	$ (0.69)	$ (0.63)	$ (2.95)
Weighted average shares outstanding-basic and diluted (in shares)	7,160,890	3,136,955	7,119,569	2,074,380